Cortical lesions in multiple sclerosis.

Although previous studies have shown that the lesions of multiple sclerosis may involve the cerebral cortex, there is little published research on the prevalence and distribution of such lesions. Using neuropathological techniques and MRI, a series of studies has been undertaken in order to assess this, in particular to identify their relationship to cortical veins. A serial MRI study showed that the use of gadolinium proffered an increase in cortical lesion detection of 140% and showed that 26% of active lesions arose within or adjacent to the cortex. In a post-mortem study, MRI under-reported lesions subsequently analysed neuropathologically, particularly those arising within the cortex. In a further 12 cases examined, 478 cortical lesions were identified, of which 372 also involved the subcortical white matter. Seven different lesion types were identified; the majority arose within the territory of the principal cortical veins, whilst the remaining quarter arose within the territory of the small branch or superficial veins. Small cortical lesions are common in multiple sclerosis and are under-reported by MRI. Investigation of the cortical venous supply shows how such lesions may arise, and why the majority also involve the underlying white matter.

[1]  W. E. Drake,et al.  Epilepsy in multiple sclerosis , 1961, Neurology.

[2]  W. Matthews Epilepsy and disseminated sclerosis. , 1962, The Quarterly journal of medicine.

[3]  B. Brownell,et al.  The distribution of plaques in the cerebrum in multiple sclerosis , 1962, Journal of neurology, neurosurgery, and psychiatry.

[4]  M. Alter,et al.  Cerebral multiple sclerosis , 1971, Neurology.

[5]  J. De Reuck The cortico-subcortical arterial angio-architecture in the human brain. , 1972, Acta Neurologica Belgica.

[6]  J. Dereuck The cortico-subcortical arterial angio-architecture in the human brain. , 1972 .

[7]  P. Trouillas,et al.  Epilepsy with Multiple Sclerosis , 1971, Epilepsia.

[8]  I. T. Draper MULTIPLE SCLEROSIS: A REAPPRAISAL , 1973, The Medical journal of Australia.

[9]  R O Barnard,et al.  Corpus callosum in multiple sclerosis , 1974, Journal of neurology, neurosurgery, and psychiatry.

[10]  S. Poser Multiple sclerosis: an ańalysis of 812 cases by means of electronic data processing. , 1979, Schriftenreihe Neurologie.

[11]  H. Duvernoy,et al.  Cortical blood vessels of the human brain , 1981, Brain Research Bulletin.

[12]  D. Silberberg,et al.  New diagnostic criteria for multiple sclerosis: Guidelines for research protocols , 1983, Annals of neurology.

[13]  Palinopsia and bitemporal visual extinction on fixation. , 1985 .

[14]  Palinopsia and bitemporal visual extinction on fixation. , 1985, Annals of ophthalmology.

[15]  W. Matthews,et al.  McAlpine's multiple sclerosis , 1985 .

[16]  F. Mastaglia,et al.  Alexia with agraphia in multiple sclerosis , 1987, Journal of the Neurological Sciences.

[17]  T. Inoue,et al.  Formalin fixed brains are useful for magnetic resonance imaging (MRI) study , 1987, Journal of the Neurological Sciences.

[18]  K Rammohan,et al.  Magnetic resonance imaging correlates of dementia in multiple sclerosis. , 1987, Archives of neurology.

[19]  R. Heaton,et al.  Cognitive loss in multiple sclerosis. Case reports and review of the literature. , 1989, Archives of neurology.

[20]  V. Haughton,et al.  Correlation of magnetic resonance imaging with neuropsychological testing in multiple sclerosis , 1989, Neurology.

[21]  P. A. Beatty,et al.  Cognitive disturbances in patients with relapsing remitting multiple sclerosis. , 1989, Archives of neurology.

[22]  B E Kendall,et al.  Breakdown of the blood-brain barrier precedes symptoms and other MRI signs of new lesions in multiple sclerosis. Pathogenetic and clinical implications. , 1990, Brain : a journal of neurology.

[23]  C. Pozzilli,et al.  Anterior Corpus Callosum Atrophy and Verbal Fluency in Multiple Sclerosis , 1991, Cortex.

[24]  E. Warrington,et al.  Cognitive abnormalities in multiple sclerosis: a psychometric and MRI study , 1991, Psychological Medicine.

[25]  F. Barkhof,et al.  The effects of high-dose methylprednisolone on gadolinium-enhanced magnetic resonance imaging and cerebrospinal fluid measurements in multiple sclerosis , 1992, Journal of Neuroimmunology.

[26]  F. Barkhof,et al.  Gadolinium enhancement increases the sensitivity of MRI in detecting disease activity in multiple sclerosis. , 1993, Brain : a journal of neurology.

[27]  A. Thompson,et al.  Seizures due to multiple sclerosis: seven patients with MRI correlations. , 1993, Journal of neurology, neurosurgery, and psychiatry.

[28]  A J Thompson,et al.  A comparison of the pathology of primary and secondary progressive multiple sclerosis. , 1994, Brain : a journal of neurology.

[29]  S. Stöppler,et al.  White matter lesions and cognitive deficits: relevance of lesion pattern? , 1994, Acta neurologica Scandinavica.

[30]  H. Tobi,et al.  Magnetic Resonance Imaging of Epilepsy in Multiple Sclerosis: A Case Control Study. Implications for Treatment Trials with 4-Aminopyridine , 1996, Multiple sclerosis.

[31]  M. Rovaris,et al.  Sensitivity and Reproducibility of Fast‐FLAIR, FSE, and TGSE Sequences for the MRI Assessment of Brain Lesion Load in Multiple Sclerosis: A Preliminary Study , 1997, Journal of neuroimaging : official journal of the American Society of Neuroimaging.

[32]  J Foong,et al.  Executive function in multiple sclerosis. The role of frontal lobe pathology. , 1997, Brain : a journal of neurology.

[33]  G. Comi,et al.  Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis. , 1997, Brain : a journal of neurology.